These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 994152)

  • 1. Synthesis and antilipidemic properties of cis-7-chloro-3a, 8b-dihydro-3a-methylfuro[3,4-b]benzofuran-3(1H)-one, a tricyclic clofibrate related lactone having a structural resemblance to mevalonolactone.
    Witiak DT; Kuwano E; Feller DR; Baldwin JR; Newman HA; Sankrappa SK
    J Med Chem; 1976 Oct; 19(10):1214-20. PubMed ID: 994152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacological evaluation of cis-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-1-ones. Tricyclic analogues related to the antilipidemic drug clofibrate.
    Witiak DT; Loh W; Feller DR; Baldwin JR; Newman HA; Sober CL; Cavestri RC
    J Med Chem; 1979 Jun; 22(6):699-705. PubMed ID: 110933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate.
    Witiak DT; Newman HA; Poochikian GK; Fogt SW; Baldwin JR; Sober CL; Feller DR
    J Med Chem; 1978 Aug; 21(8):833-7. PubMed ID: 99517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antilipidemic activity of 4-oxo-functionalized ethyl 6-chlorochroman-2-carboxylate analogs and a related tricyclic lactone in three rat models.
    Cavestri RC; Minatelli JA; Baldwin JR; Loh W; Feller DR; Newman HA; Sober CL; Witiak DT
    Lipids; 1981 Jan; 16(1):30-6. PubMed ID: 7219078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of a clofibrate-related tricyclic spirolactone, 5-chloro-4',5-dihydrospiro[benzofuran-2(3H),3'(2'H)-furan]-2'-one.
    Witiak DT; Cavestri RC; Newman HA; Baldwin JR; Sober CL; Feller DR
    J Med Chem; 1978 Dec; 21(12):1198-202. PubMed ID: 722728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9-Chloro-2,3-dihydro-5H-1,4-dioxepino(6,5-b)benzofuran, a novel antilipidemic agent structurally related to clofibrate.
    Witiak DT; Poochikian GK; Feller DR; Kenfield NA; Newman HA
    J Med Chem; 1975 Oct; 18(10):992-6. PubMed ID: 1159693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antilipidemic effects of various ethyl 5-substituted benzofuran-, 2,3-dihydrobenzofuran-, and 3(2H)-benzofuranone-2-carboxylate analogs of clofibrate in a triton hyperlipidemic rat model.
    Witiak DT; Newman HA; Poochikian GK; Loh W; Sankarappa SK
    Lipids; 1976 May; 11(5):384-91. PubMed ID: 1271976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological studies of 3-amino-2-methyl-1-phenyl-propanones as hypolipidemic agents in rodents.
    Huang Y; Hall IH
    Arch Pharm (Weinheim); 1996 Jul; 329(7):329-38. PubMed ID: 8764881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hypocholesterolemic activity for cyclic analogs of clofibrate in normolipemic rats.
    Goldberg AP; Mellon WS; Witiak DT; Feller DR
    Atherosclerosis; 1977 May; 27(1):15-25. PubMed ID: 857813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action of the lipid-lowering agents, clofibrate and BM 15075, on cholesterol biosynthesis in rat liver.
    Berndt J; Gaumert R; Still J
    Atherosclerosis; 1978 Jun; 30(2):147-52. PubMed ID: 678316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of 3,5-isoxazolidinediones as hypolipidemic agents in rodents.
    Woodard T; Debnath ML; Simlot R; Izydore RA; Daniels DL; Wong OT; ElSourady H; Hall IH
    Pharm Res; 1995 Jan; 12(1):24-38. PubMed ID: 7724485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice.
    Jiang C; Wang Q; Wei Y; Yao N; Wu Z; Ma Y; Lin Z; Zhao M; Che C; Yao X; Zhang J; Yin Z
    J Ethnopharmacol; 2015 Dec; 176():17-26. PubMed ID: 26477373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow-fed animals.
    O'Brien M; Patel ST; Mukhopadhyay A; Newman HA; Feller DR; Kokrady SS; Witiak DT; Lanese RR; Rice JC
    Lipids; 1981 Dec; 16(12):903-11. PubMed ID: 7329211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of clofibrate and its analogs in rats. Dissociation of hypolipidemic effects and the induction of peroxisomal beta-oxidation.
    Harrison EH
    Biochim Biophys Acta; 1984 Nov; 796(2):163-8. PubMed ID: 6541949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypolipidemic activity of 3-amino-1-(2,3,4-mononitro-, mono-, or dihalophenyl)propan-1-ones in rodents.
    Huang Y; Hall IH
    Arch Pharm (Weinheim); 1996 Jul; 329(7):339-46. PubMed ID: 8764882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isonicotinates, nicotinates and clofibrates of N-methyl-N-(2-hydroxyethyl or 3-hydroxypropyl)--1,3,3-trimethylbicyclo [2.2.1]heptan-2-endo-amine with hypocholesterolemic and hypolipidemic activity.
    Bondavalli F; Bruno O; Schenone P; Vacca C; De Carlo R; Marmo E
    Farmaco Sci; 1987 Apr; 42(4):251-7. PubMed ID: 3595837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid.
    Haughom B; Spydevold O
    Biochim Biophys Acta; 1992 Sep; 1128(1):65-72. PubMed ID: 1327145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The results of animal studies with ciprofibrate, a new orally effective hypolipidemic drug.
    Arnold A; McAuliff JP; Powers LG; Phillips DK; Beyler AL
    Atherosclerosis; 1979 Feb; 32(2):155-63. PubMed ID: 454514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-hyperlipidemic effect of iodine eggs: studies on the mechanism of its action].
    Kaji K; Miyashita M; Seyama Y; Yamashita S
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):451-7. PubMed ID: 6469134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and hypolipidemic activity of 2-substituted isobutyric acid derivatives.
    Morishita S; Saito T; Hirai Y; Shoji M; Mishima Y; Kawakami M
    J Med Chem; 1988 Jun; 31(6):1205-9. PubMed ID: 3163736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.